Can a tablet app ease loneliness in older HIV patients?
NCT ID NCT06560970
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested a tablet-based app called COPPEhR designed to help older adults with HIV (age 50+) connect with others, access resources, and reduce loneliness. Sixty-eight participants either got the app or a tablet without it. The main goal was to see if the app was easy to use and helpful, not to prove it improves health. Researchers also measured changes in depression and social support.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
COPPEhR app (a tablet-based software application for social engagement and resource access)
What this could lead to
If it works, this could offer a practical way to improve social connection and mental health for older adults living with HIV.
What could go wrong
This was a small pilot study with only 68 participants, so results may not apply to everyone. The app's benefits are not yet proven in larger trials.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV DIAGNOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Weill Cornell Medicine
New York, New York, 10065, United States